Charles Schwab’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-41,084
| Closed | -$68K | – | 3729 |
|
|
2022
Q1 | $68K | Sell |
41,084
-8,510
| -17% | -$14.1K | ﹤0.01% | 3483 |
|
|
2021
Q4 | $119K | Hold |
49,594
| – | – | ﹤0.01% | 3420 |
|
|
2021
Q3 | $271K | Sell |
49,594
-90,884
| -65% | -$497K | ﹤0.01% | 3286 |
|
|
2021
Q2 | $1.05M | Buy |
140,478
+14,566
| +12% | +$108K | ﹤0.01% | 2909 |
|
|
2021
Q1 | $1.02M | Buy |
125,912
+35,348
| +39% | +$286K | ﹤0.01% | 2852 |
|
|
2020
Q4 | $825K | Sell |
90,564
-4,850
| -5% | -$44.2K | ﹤0.01% | 2827 |
|
|
2020
Q3 | $1.06M | Buy |
95,414
+55,094
| +137% | +$610K | ﹤0.01% | 2663 |
|
|
2020
Q2 | $300K | Sell |
40,320
-897
| -2% | -$6.67K | ﹤0.01% | 3047 |
|
|
2020
Q1 | $254K | Buy |
41,217
+402
| +1% | +$2.48K | ﹤0.01% | 2943 |
|
|
2019
Q4 | $205K | Buy |
40,815
+12,796
| +46% | +$64.3K | ﹤0.01% | 3035 |
|
|
2019
Q3 | $211K | Sell |
28,019
-2,370
| -8% | -$17.8K | ﹤0.01% | 3032 |
|
|
2019
Q2 | $353K | Buy |
+30,389
| New | +$353K | ﹤0.01% | 2963 |
|